Crinetics Pharmaceuticals CRNX Stock options exercised receivable
Stock options exercised receivable at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept crnx:OptionsExerciseReceivable.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's stock options exercised receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's stock options exercised receivable?
- Crinetics Pharmaceuticals (CRNX) reported stock options exercised receivable of $3K in Q1 2026.
- How has Crinetics Pharmaceuticals's stock options exercised receivable changed year-over-year?
- Crinetics Pharmaceuticals's stock options exercised receivable decreased by 80.0% year-over-year, from $15K to $3K.
- What does stock options exercised receivable mean?
- This represents the amount owed to the company by individuals who have exercised stock options but have not yet settled the payment in cash. It acts as a short-term asset reflecting pending cash inflows from equity-based compensation activities. Monitoring this helps in understanding the timing differences between the exercise of options and the actual receipt of cash.